Eiref-40 Tablet
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Eiref-40 Tablet
Gastric acid secretion is diminished by Acired-40 tablets, a medication employed in managing various stomach and intestinal ailments stemming from excess acidity. These include heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering both symptomatic relief and promoting healing. Acired-40 also prevents ulcers and hyperacidity often associated with extended nonsteroidal anti-inflammatory drug (NSAID) use. Classified as a proton pump inhibitor (PPI), it's best taken orally one hour prior to meals, ideally in the morning. Dosage is individualized, contingent upon your condition and response. Continue the prescribed regimen even with rapid symptom resolution. Dietary modifications, such as frequent smaller meals and avoiding caffeine, spicy foods, and fatty meals, enhance treatment efficacy. Common, usually mild, adverse effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Persistent or bothersome side effects warrant medical consultation. Prolonged use, particularly exceeding one year, may elevate the risk of fractures, especially at higher doses. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your physician. Prior to commencing treatment, inform your doctor of any severe liver impairment, HIV medication use, prior adverse reactions to similar medications, or pre-existing osteoporosis. This medication requires medical consultation before use by pregnant or breastfeeding individuals.
Primary Ingredients of Eiref-40 Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Eiref-40 Tablet
Managing heartburn, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Eiref-40 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eiref-40 on an empty stomach.
Common Side effects of Eiref-40 Tablet:
- Diarrhea
- Flatulence
- Headache
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Upper respiratory tract infection
How to use Eiref-40 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eiref-40 Tablets should be taken on an empty stomach.
How Eiref-40 Tablet works:
Gastric acid production is decreased by the proton pump inhibitor Eiref-40 Tablet, thus providing relief from heartburn and indigestion caused by excess stomach acid.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Eiref-40 Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Eiref-40 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Eiref-40 Tablet use appear compatible. Available evidence from human studies indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Eiref-40 Tablet.
KidneySAFE IF PRESCRIBED
Eiref-40 Tablets pose no safety concerns for individuals with kidney disease; no dosage alteration is necessary.
LiverCAUTION
Patients with severe hepatic impairment should use Eiref-40 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Eiref-40 Tablet :
Should you forget to take your Eiref-40 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eiref-40 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |





